Fluid Biomed Inc. completed a $27m #SeriesA equity financing round to advance the development of its innovative ReSolv stent for treating brain aneurysms. Led by Amplitude Ventures, the oversubscribed #fundinground also included participation from new investors, including IAG Capital Partners and LifeArc Ventures and returning investors ShangBay Capital and METIS Innovative. CEO Dr John Wong shared: “Our exclusive technology has attracted the attention of international investors of the highest calibre with the depth and breadth of expertise to accelerate company evolution and make its medical devices available sooner to physicians and patients.” 💬 Read more: https://lnkd.in/dn82adJe #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
GS Capital Connect
Investment Advice
Connecting early-stage MedTechs to Global Investment Capital
About us
GS Capital Connect is the bridge between innovative, emerging companies that are looking to raise capital and our active, engaged and growing ecosystem of 3000+ investors in MedTech. We provide greater visibility for MedTech start-ups empowering them to bring structure, speed and efficiency to their fundraising and investor relations. Our team have been supporting MedTech start-ups in developing their compelling stories since 2000, and we are confident we can help you craft a clear and precise investor communication strategy that will help you secure the next investment round.
- Website
-
http://www.gscapitalconnect.com
External link for GS Capital Connect
- Industry
- Investment Advice
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
London, GB
Employees at GS Capital Connect
Updates
-
#Oncology #MedTech BetaGlue Therapeutics shared the ENEA Tech e Biomedical invested €6m, bringing the total raised in the current funding round to €24m. This investment follows the €8m #equityfinancing round and the €10m EIC Accelerator Award announced in June of this year. "[W]e are building a platform technology that has the potential to provide easy-to-use, targeted and personalised life-changing therapies for a wide range of solid tumour cancer patients” said Dr Colin Story , CEO of BetaGlue. 🔗 Read the full story: https://lnkd.in/dcFN-GAT #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
ENEA-Tech Biomedical foundation invests €6m in BetaGlue Therapeutics
https://news.gsmedtech.com
-
Tromp Medical BV, Europe’s largest independent medical imaging sales and service organization, has attracted Gilde Healthcare as new investor, alongside Capital A Investment Partners, to drive further growth in the medical imaging market. 💬 Konrad Eichberger, CEO of Tromp Medical commented: “Gilde Healthcare’s proven expertise and visionary approach will be instrumental as we push the boundaries of innovation and expand our impact in the Medical imaging market.” 🔗 Learn more: https://lnkd.in/dnk8i-gb #MedicalDevices #MedicalEquipment #HealthTech #Headhunter #TalentManagement #Leadership #LeadershipDevelopment #GuidedSolutions #ExecutiveSearch #Executive #Csuite #MedTechExecutiveSearch
Tromp Medical wins funding to drive growth in the medical imaging market
https://news.gsmedtech.com
-
Start-up LaNua Medical will use these funds to develop ‘Ecore’, an umbrella-shaped device which intends to modernise embolisation procedures, and expand in the US. The #seedfundinground was co-led by Elkstone and Atlantic Bridge, with participation from Enterprise Ireland and Furthr VC. 💬 "It will enable our team to hire additional skilled resources, develop a range of devices to meet the growing demands of embolisation in the interventional radiology medical community and gain entry into our first market in the US,” CEO Tom Fitzmaurice said of this funding round. 🔗 Read more: https://lnkd.in/dhxPcFxk #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
LaNua Medical raised €6m in seed funding for Ecore device
https://news.gsmedtech.com
-
👏 Capstan Medical has raised $110 million in new funding from an oversubscribed #SeriesC round, led by Eclipse, with participation from Yu Galaxy and Intuitive Ventures, as well as first-time investor Gideon Strategic Partners. “We had such strong internal support for giving us this runway for the next phase of the business that we only added a single investor into the mix for this round, which was fantastic,” Capstan Medical CEO Maggie Nixon said. 🔗 Learn more: https://lnkd.in/d-MhbYvS #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Capstan Medical raises $110m in Series C round ahead of structural heart robot’s first-in-human procedure
https://news.gsmedtech.com
-
Saventic Health, a #startup advancing the diagnosis of rare diseases using #AI, secured €1.9 million in bridge funding from international investors. This investment was led by 4growth VC in co-investment with Poland’s NCBR Investment Fund ASI S.A. and TNI Fund. 💬 “Our international presence confirms that our algorithms are effective and well-received by our clients and partners,” said Szymon Piatkowski, Co-founder and CEO of Saventic Health. 🔗Read more: https://lnkd.in/dfRS7au5 #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Saventic Health raises €1.9 million to diagnose rare diseases with AI
https://news.gsmedtech.com
-
Cala Health, the non-invasive bioelectronic medicine leader, completed the initial closing of an oversubscribed $50 million growth round to propel Cala's commercialisation trajectory. The round was co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. All existing Cala investors participated in the round, including Action Potential Venture Capital, Johnson & Johnson Innovation JJDC Inc, Lightstone Ventures, Lux Capital, (GV (Google Ventures)), OSF Ventures, Ascension Ventures, Triventures, Reimagined Ventures, PEAK6 and Fiscus. 🚀 "[The funding]allows us to broaden patient and physician awareness of this effective and innovative treatment," said Deanna Harshbarger, Cala CEO." 👉 Learn more: https://lnkd.in/em4Kk5Da #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Cala Health closes oversubscribed $50m financing to propel growth
https://news.gsmedtech.com
-
Wanda Health, the intelligent platform for Remote Patient Monitoring and #VirtualCare, announced it closed a £1 million equity investment round to help expand its US sales growth, execute its AI product roadmap, and scale its operations to meet the demands of the rapidly expanding #digitalhealth market. 👏 The EIS investment round was led by EMV Capital plc Partners. 💬 Tom Smith, Chief Executive Officer, shared: "We are clear in our mission to deliver the best in class intelligent virtual care across acute, chronic and speciality diseases and now we have the firepower to execute it." 🔗 Read more: https://lnkd.in/eteSVAyw #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Wanda Health secures funding to accelerate growth
https://news.gsmedtech.com
-
🚀Cleerly concluded a $106m #SeriesC funding round to advance its #AI-driven coronary artery disease platform. The round was led by software investor Insight Partners and was joined by Battery Ventures, along with pre-existing investors. Founder and CEO Dr James Min, MD commented: “We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heart attacks.” 👉 Learn more: https://lnkd.in/dSjqteXj #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Cleerly raises $106m to advance AI imaging platform for heart disease
https://news.gsmedtech.com
-
👼 NUA SURGICAL concluded a €6.5m #SeriesA #fundinground to advance its caesarean surgery (C-section) assistance device. The round was led by new investor EQT Life Sciences, which invested through its EQT Health Economics strategy and featured participation from other new investors, including Texas Medical Center Venture Fund and Kidron Capital Assets LP, as well as existing investors such as Enterprise Ireland. CEO Barry Mc Cann commented: “Securing this Series A financing is a crucial milestone for Nua Surgical." 🔗 https://lnkd.in/dBHh5PCu #MedicalDevice #MedTech #MedicalEquipment #HealthTech #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect
Nua Surgical raises €6.5m to advance C-section surgical assistance device
https://news.gsmedtech.com